These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33970902)

  • 21. Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor.
    Abuin-Martínez C; Vidal R; Gutiérrez-López MD; Pérez-Hernández M; Giménez-Gómez P; Morales-Puerto N; O'Shea E; Colado MI
    Neuropharmacology; 2021 Apr; 187():108490. PubMed ID: 33607146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.
    Escubedo E; Abad S; Torres I; Camarasa J; Pubill D
    Neurochem Int; 2011 Jan; 58(1):92-101. PubMed ID: 21074589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect modification of tumor necrosis factor-α on the kynurenine and serotonin pathways in major depressive disorder on type 2 diabetes mellitus.
    Okamoto N; Hoshikawa T; Honma Y; Chibaatar E; Ikenouchi A; Harada M; Yoshimura R
    Eur Arch Psychiatry Clin Neurosci; 2024 Oct; 274(7):1697-1707. PubMed ID: 37991535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pharmacological treatment on metabolomic alterations in animal models of depression.
    Pu J; Liu Y; Gui S; Tian L; Yu Y; Wang D; Zhong X; Chen W; Chen X; Chen Y; Chen X; Gong X; Liu L; Li W; Wang H; Xie P
    Transl Psychiatry; 2022 Apr; 12(1):175. PubMed ID: 35487889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol disrupts tryptophan metabolism in the human term placenta.
    Portillo R; Abad C; Synova T; Kastner P; Heblik D; Kucera R; Karahoda R; Staud F
    Toxicology; 2024 Jun; 505():153813. PubMed ID: 38663822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.
    Pawlowski T; Pawlak D; Inglot M; Zalewska M; Marciniak D; Bugajska J; Janocha-Litwin J; Malyszczak K
    J Psychiatry Neurosci; 2021 Jan; 46(1):E166-E175. PubMed ID: 33464780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
    da Silva Dias IC; Carabelli B; Ishii DK; de Morais H; de Carvalho MC; Rizzo de Souza LE; Zanata SM; Brandão ML; Cunha TM; Ferraz AC; Cunha JM; Zanoveli JM
    Mol Neurobiol; 2016 Dec; 53(10):6997-7009. PubMed ID: 26671617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N; Schwarz MJ
    Mol Psychiatry; 2007 Nov; 12(11):988-1000. PubMed ID: 17457312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies.
    Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S
    Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies.
    Bansal Y; Singh R; Sodhi RK; Khare P; Dhingra R; Dhingra N; Bishnoi M; Kondepudi KK; Kuhad A
    Neuropharmacology; 2022 Sep; 215():109169. PubMed ID: 35753430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
    Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease.
    Whiley L; Chappell KE; D'Hondt E; Lewis MR; Jiménez B; Snowden SG; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Swann JR; Hye A; Lovestone S; Legido-Quigley C; Holmes E;
    Alzheimers Res Ther; 2021 Jan; 13(1):20. PubMed ID: 33422142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.
    Dornbierer DA; Boxler M; Voegel CD; Stucky B; Steuer AE; Binz TM; Baumgartner MR; Baur DM; Quednow BB; Kraemer T; Seifritz E; Landolt HP; Bosch OG
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):631-639. PubMed ID: 31504554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Models of dopaminergic and serotonergic signaling.
    Best J; Reed M; Nijhout HF
    Pharmacopsychiatry; 2010 May; 43 Suppl 1():S61-6. PubMed ID: 20480448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous quantification of neuroactive dopamine serotonin and kynurenine pathway metabolites in gender-specific youth urine by ultra performance liquid chromatography tandem high resolution mass spectrometry.
    Lu H; Yu J; Wang J; Wu L; Xiao H; Gao R
    J Pharm Biomed Anal; 2016 Apr; 122():42-51. PubMed ID: 26845201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depression.
    Achtyes E; Keaton SA; Smart L; Burmeister AR; Heilman PL; Krzyzanowski S; Nagalla M; Guillemin GJ; Escobar Galvis ML; Lim CK; Muzik M; Postolache TT; Leach R; Brundin L
    Brain Behav Immun; 2020 Jan; 83():239-247. PubMed ID: 31698012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.
    Bansal Y; Singh R; Saroj P; Sodhi RK; Kuhad A
    Toxicol Appl Pharmacol; 2018 Sep; 355():257-268. PubMed ID: 30017640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.
    Engin AB; Engin A
    Adv Exp Med Biol; 2024; 1460():629-655. PubMed ID: 39287867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder.
    Maget A; Platzer M; Bengesser SA; Fellendorf FT; Birner A; Queissner R; Hamm C; Reininghaus B; Hecker A; Tomberger L; Pilz R; Dalkner N; Moll N; Schütze G; Schwarz M; Kapfhammer HP; Reininghaus EZ
    Curr Top Med Chem; 2020; 20(15):1344-1352. PubMed ID: 31376822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.
    Müller N
    Curr Opin Investig Drugs; 2010 Jan; 11(1):31-42. PubMed ID: 20047157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.